Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al
Caoilfhionn M Connolly, Darya Koenig, Srekar Ravi, Antoine Azar, Sam Kant, Monika Dalal, Jessica Duchen, Philip Seo, Brendan Antiochos, Julie J. Paik, Duvuru Geetha
Topics & Concepts
MedicineRituximabImmunologyImmunogenicityAntibodyVaccinationImmune systemInternal medicineVasculitis and related conditionsSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis